← Open Payments lookup

KYLA SCHAUSS: Open Payments

NPI 1003407321 · MISHAWAKA, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$540 in 23 payments from 16 companies in 2025. Trend: 2023 $45 · 2024 $298 · 2025 $540

Food & beverage: $540
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation3$73
Genmab U.S., Inc.2$56
Adaptive Biotechnologies Corporation2$52
Regeneron Healthcare Solutions, Inc.2$49
Janssen Biotech, Inc.2$45
AstraZeneca Pharmaceuticals LP2$40
ADC THERAPEUTICS AMERICA, INC.1$36
Boehringer Ingelheim Pharmaceuticals, Inc.1$35
E.R. Squibb & Sons, L.L.C.1$34
BeOne Medicines USA, Inc.1$22

Products named: KISQALI, Tivdak, clonoSEQ, LIBTAYO, ZYNLONTA, OPDIVO, ERLEADA, BRUKINSA.

Industry payments across IN — which companies pay providers there.